Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1.
AUTOR(ES)
van Veen, H W
RESUMO
Resistance of Lactococcus lactis to cytotoxic compounds shares features with the multidrug resistance phenotype of mammalian tumor cells. Here, we report the gene cloning and functional characterization in Escherichia coli of LmrA, a lactococcal structural and functional homolog of the human multidrug resistance P-glycoprotein MDR1. LmrA is a 590-aa polypeptide that has a putative topology of six alpha-helical transmembrane segments in the N-terminal hydrophobic domain, followed by a hydrophilic domain containing the ATP-binding site. LmrA is similar to each of the two halves of MDR1 and may function as a homodimer. The sequence conservation between LmrA and MDR1 includes particular regions in the transmembrane domains and connecting loops, which, in MDR1 and the MDR1 homologs in other mammalian species, have been implicated as determinants of drug recognition and binding. LmrA and MDR1 extrude a similar spectrum of amphiphilic cationic compounds, and the activity of both systems is reversed by reserpine and verapamil. As LmrA can be functionally expressed in E. coli, it offers a useful prokaryotic model for future studies on the molecular mechanism of MDR1-like multidrug transporters.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=38212Documentos Relacionados
- Cell-specific activity of cis-acting regulatory elements in the promoter of the mouse multidrug resistance gene mdr1.
- Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids
- Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene.
- HIV-1 protease inhibitors and the MDR1 multidrug transporter.
- A polymorphic HindIII site within the human multidrug resistance gene 1 (MDR1).
